Portal de Periódicos da CAPES

COVID‐19 in patients with sickle cell disease: A single center experience from Ohio, United States

2021; Wiley; Volume: 93; Issue: 5 Linguagem: Inglês

10.1002/jmv.26816

1096-9071

Kamal Kant Sahu, Laeth George, Nelroy Jones, Ankit Mangla,

COVID-19 Clinical Research Studies

Journal of Medical VirologyVolume 93, Issue 5 p. 2591-2594 LETTER TO THE EDITOR COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States Kamal Kant Sahu MD, Kamal Kant Sahu MD orcid.org/0000-0002-0382-6882 Saint Vincent Hospital, Worcester, Massachusetts, USASearch for more papers by this authorLaeth George MD, Laeth George MD Department of Internal Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorNelroy Jones MD, Nelroy Jones MD Division of Hematology and Oncology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorAnkit Mangla MD, Corresponding Author Ankit Mangla MD [email protected] orcid.org/0000-0002-6789-4315 Division of Hematology and Oncology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA Developmental Therapeutics Program, Case Comprehensive Cancer Center, Cleveland, Ohio, USA Correspondence Ankit Mangla, MD, Hematology and Oncology, Developmental Therapeutics Program, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland 44106, OH. Email: [email protected]Search for more papers by this author Kamal Kant Sahu MD, Kamal Kant Sahu MD orcid.org/0000-0002-0382-6882 Saint Vincent Hospital, Worcester, Massachusetts, USASearch for more papers by this authorLaeth George MD, Laeth George MD Department of Internal Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorNelroy Jones MD, Nelroy Jones MD Division of Hematology and Oncology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorAnkit Mangla MD, Corresponding Author Ankit Mangla MD [email protected] orcid.org/0000-0002-6789-4315 Division of Hematology and Oncology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA Developmental Therapeutics Program, Case Comprehensive Cancer Center, Cleveland, Ohio, USA Correspondence Ankit Mangla, MD, Hematology and Oncology, Developmental Therapeutics Program, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland 44106, OH. Email: [email protected]Search for more papers by this author First published: 21 January 2021 https://doi.org/10.1002/jmv.26816Citations: 8Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Sahu KK, Kumar R. Current perspective on pandemic of COVID-19 in the United States. J Family Med Prim Care. 2020; 9(4): 1784. 10.4103/jfmpc.jfmpc_424_20 PubMedGoogle Scholar 2Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020. 10.1093/cid/ciaa538 Web of Science®Google Scholar 3Sahu KK, Siddiqui AD, Cerny J Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020. 10.1111/bjh.16880 PubMedWeb of Science®Google Scholar 4Panepinto JA, Brandow A, Mucalo L, et al. Early release—coronavirus disease among persons with sickle cell disease, United States, March 20–May 21, 2020. Emerging Infect Dis J. 2020;(10). https://wwwnc.cdc.gov/eid/article/26/10/20-2792_article PubMedWeb of Science®Google Scholar 5Arlet J-B, de Luna G, Khimoud D, et al. Prognosis of patients with sickle cell disease and COVID-19: a French experience. Lancet Haematol. 2020. Google Scholar 6Chakravorty S, Padmore-Payne G, Ike F, et al. COVID-19 in patients with sickle cell disease—a case series from a UK Tertiary Hospital. Haematologica. 2020. Google Scholar 7McCloskey KA, Meenan J, Hall R, Tsitsikas DA. COVID-19 infection and sickle cell disease: a UK centre experience. Br J Haematol. 2020; 190(2): e57-e58. 10.1111/bjh.16779 CASPubMedWeb of Science®Google Scholar Citing Literature Volume93, Issue5Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐XIIMay 2021Pages 2591-2594 ReferencesRelatedInformation